Rigel Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Fair Value (Tables)

Fair Value (Tables)

6 Months Ended

Jun. 30, 2014

Schedule of financial assets measured at fair value on a recurring basis

Financial assets measured at fair value on a recurring basis are categorized in the tables below based upon the lowest level of significant input to the valuations (in thousands):

	Assets at Fair Value as of June 30, 2014
	Level 1		Level 2		Level 3		Total
Money market funds	$	12,482	$	—	$	—	$	12,482
U. S. treasury bills	—		2,049		—		2,049
Government-sponsored enterprise securities	—		57,510		—		57,510
Corporate bonds and commercial paper	—		103,588		—		103,588
Total	$	12,482	$	163,147	$	—	$	175,629

	Assets at Fair Value as of December 31, 2013
	Level 1		Level 2		Level 3		Total
Money market funds	$	9,059	$	—	$	—	$	9,059
U. S. treasury bills	—		2,085		—		2,085
Government-sponsored enterprise securities	—		67,178		—		67,178
Corporate bonds and commercial paper	—		133,458		—		133,458
Total	$	9,059	$	202,721	$	—	$	211,780